Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...

In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.

The initiative, titled 'The Court Is Hers,' eliminates registration fees for girls basketball programs at the YMCA.

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...

The iPhone maker's shares [rallied for a second day]( ...

Eli Lilly (LLY) recently introduced EBGLYSS through Senderra Specialty Pharmacy, targeting patients with atopic dermatitis, while enhancing patient and provider experiences via SenderraCare+. Despite ...